SCHEMBL17358249

SCHEMBL17358249

Cc1cc(OCc2ccccc2)c2c(c1)O[C@H](c1ccc(OCc3ccccc3)c(C)c1)[C@@H](O)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ FFAR4 Q5NUL3 3/20 0.43
▸ BACE1 P56817 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ GAA P10253 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ PKM P14618 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ APEX1 P27695 2/20 0.41
▸ RECQL P46063 2/20 0.41
▸ ALPL P05186 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ PTGS1 P23219 2/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ APP P05067 1/20 0.41
▸ AMY1A P0DUB6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15450263 0.93 CYP3A4 (0.44) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL15450266 0.93 CYP3A4 (0.44) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL16016915 0.93 CYP3A4 (0.44) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL15450257 0.93 CYP3A4 (0.44) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL17523257 0.90 CYP3A4 (0.42) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL17523259 0.90 CYP3A4 (0.42) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL17358243 0.89 KDM4E (0.56) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL10016120 0.86 STING1 (0.46) CYP3A4MAPK1BACE1KDM4EMEN1
SCHEMBL5839219 0.81 STING1 (0.43) CYP3A4MAPK1BACE1KDM4EGAA
SCHEMBL24983638 0.81 CYP3A4 (0.50) CYP3A4MAPK1BACE1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC. 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS NQO1, COMT, NNMT CYP3A4 144/4885MAPK1 2894/4885FFAR4 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback